Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(StreetInsider) Oct 17, 2017 - AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) for the treatment of patients with locally advanced (Stage III) unresectable...
Read Article
(AstraZeneca) Oct 17, 2017 - AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) for the treatment of patients with locally advanced (Stage III) unresectable...
Read Article
Latest Articles
October 17, 2017
October 17, 2017
October 17, 2017
October 17, 2017
October 17, 2017
October 16, 2017
October 16, 2017
October 16, 2017
View More
News Commentary
Editor Image
06 Mar, 2017 | by H. Jack West, MD
I'm dubious about a 62% specificity. The test doesn't conclusively rule out...
View Comment
Editor Image
24 Mar, 2017 | by H. Jack West, MD
It's striking that we've needed yet another revision of the NCCN guidelines in...
View Comment
View More
OBR Green
There are no Lung (includes NSCLC, SCLC, Mesothelioma) OBR Green articles.
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.